166 related articles for article (PubMed ID: 19416087)
1. The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Duysen EG; Li B; Lockridge O
Expert Opin Drug Metab Toxicol; 2009 May; 5(5):523-8. PubMed ID: 19416087
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
3. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
4. The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency.
Li B; Duysen EG; Carlson M; Lockridge O
J Pharmacol Exp Ther; 2008 Mar; 324(3):1146-54. PubMed ID: 18056867
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
6. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
[TBL] [Abstract][Full Text] [Related]
7. Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism.
Xing S; Li Q; Xiong B; Chen Y; Feng F; Liu W; Sun H
Med Res Rev; 2021 Mar; 41(2):858-901. PubMed ID: 33103262
[TBL] [Abstract][Full Text] [Related]
8. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice.
Duysen EG; Li B; Carlson M; Li YF; Wieseler S; Hinrichs SH; Lockridge O
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):514-21. PubMed ID: 19067679
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for Live-Cell and In Vivo Imaging.
Liu SY; Xiong H; Yang JQ; Yang SH; Li Y; Yang WC; Yang GF
ACS Sens; 2018 Oct; 3(10):2118-2128. PubMed ID: 30203965
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet.
Chen VP; Gao Y; Geng L; Stout MB; Jensen MD; Brimijoin S
Endocrinology; 2016 Aug; 157(8):3086-95. PubMed ID: 27300766
[TBL] [Abstract][Full Text] [Related]
12. Production of the butyrylcholinesterase knockout mouse.
Li B; Duysen EG; Saunders TL; Lockridge O
J Mol Neurosci; 2006; 30(1-2):193-5. PubMed ID: 17192674
[TBL] [Abstract][Full Text] [Related]
13. Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
Darvesh S; Reid GA
Chem Biol Interact; 2016 Nov; 259(Pt B):307-312. PubMed ID: 27091549
[TBL] [Abstract][Full Text] [Related]
14. Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse.
Maurice T; Strehaiano M; Siméon N; Bertrand C; Chatonnet A
Behav Brain Res; 2016 Jan; 296():351-360. PubMed ID: 26306824
[TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis.
Chen VP; Gao Y; Geng L; Brimijoin S
Int J Obes (Lond); 2017 Sep; 41(9):1413-1419. PubMed ID: 28529331
[TBL] [Abstract][Full Text] [Related]
16. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.
Li B; Stribley JA; Ticu A; Xie W; Schopfer LM; Hammond P; Brimijoin S; Hinrichs SH; Lockridge O
J Neurochem; 2000 Sep; 75(3):1320-31. PubMed ID: 10936216
[TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase deficiency.
Delacour H; Dedome E; Courcelle S; Hary B; Ceppa F
Ann Biol Clin (Paris); 2016 Jun; 74(3):279-85. PubMed ID: 27237801
[TBL] [Abstract][Full Text] [Related]
18. Resistance to organophosphorus agent toxicity in transgenic mice expressing the G117H mutant of human butyrylcholinesterase.
Wang Y; Boeck AT; Duysen EG; Van Keuren M; Saunders TL; Lockridge O
Toxicol Appl Pharmacol; 2004 May; 196(3):356-66. PubMed ID: 15094306
[TBL] [Abstract][Full Text] [Related]
19. Localization of butyrylcholinesterase at the neuromuscular junction of normal and acetylcholinesterase knockout mice.
Blondet B; Carpentier G; Ferry A; Chatonnet A; Courty J
J Histochem Cytochem; 2010 Dec; 58(12):1075-82. PubMed ID: 20805581
[TBL] [Abstract][Full Text] [Related]
20. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
